14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 114 days ( 0 % )
Last Price $10.08 0 %
High/ Low $10.08 - $10.08 0%
Chg 7 Days N/A $10.08 $10.08
Chg 30 Days N/A $10.08 $10.08
Chg 12 mos 48.89 % $6.77 $10.08
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 36.25 % Width: 63.06 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $10.93 - $17.82 8.43 % - 76.81 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Aug 08, 2022 - 120 days
Long MA avg 12 mos Sell Nov 07, 2022 - 56 days
Short/Long MA avg 12 mos Sell Nov 07, 2022 - 56 days
Pivot Short Buy Jan 26, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Radius Health

Radius Health Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is... RDUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT